Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil 5 mg Once Daily vs Placebo in Erectile Dysfunction
2006-002922-51Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in erectile dysfunction (ED) comparing Tadalafil 5 mg once daily with Placebo once daily (2 arms). Primary endpoints: Change in Erectile Function Domain of IIEF, SEP diary question 2 and 1 more. Started Sep 2006; status: completed.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on 2006-002922-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002922-51.